PuriBlood Medical Co (ROCO:6847) LT-Debt-to-Total-Asset : 0.17 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. PuriBlood Medical Co's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.17.

PuriBlood Medical Co's long-term debt to total assets ratio increased from Jun. 2023 (0.15) to Jun. 2024 (0.17). It may suggest that PuriBlood Medical Co is progressively becoming more dependent on debt to grow their business.

PuriBlood Medical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for PuriBlood Medical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuriBlood Medical Co LT-Debt-to-Total-Asset Chart

PuriBlood Medical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.34

0.16

0.10

0.16

0.17

PuriBlood Medical Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial						0.18	0.16	0.15	0.17	0.17

PuriBlood Medical Co LT-Debt-to-Total-Asset Calculation

PuriBlood Medical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	43.701	/	265.512
	=	0.16

PuriBlood Medical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	39.74	/	241.002
	=	0.16

PuriBlood Medical Co (ROCO:6847) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

PuriBlood Medical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

PuriBlood Medical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN

Website

https://puriblood.com

PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology provides protection to support living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Seperation, and P-tex.

PuriBlood Medical Co Headlines

No Headlines